Risk of interstitial lung disease with the use of programmed cell death 1 (PD-1) inhibitor compared with programmed cell death ligand 1 (PD-L1) inhibitor in patients with breast cancer: A systematic review and meta-analysis
| Autor: | Guo, Lijuan, Lin, Xiaoyi, Lin, Xin, Wang, Yulei, Lin, Jiali, Zhang, Yi, Chen, Xiangqing, Chen, Miao, Zhang, Guochun, Zhang, Yifang |
|---|---|
| Zdroj: | In Cancer Pathogenesis and Therapy April 2024 2(2):91-102 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|